Search by job, company or skills
Work Schedule
Standard (Mon-Fri)Environmental Conditions
OfficeReview and analyze materials requirements for production and execute the necessary actions such as
generating Purchase Order, scheduling and re-scheduling of material based on MRP requirement.
Manage supplier base to achieve delivery performance and negotiate with supplier to ensure optimum cost
competitiveness. To provide guidance to Junior Buyer on day to day Purchasing functions.
Responsible to generate and maintain Supply Chain Metrics on a monthly basis.
Analyze Material obsolescence and report excess material exposure when the product is discontinued.
Organize with Purchasing Team to review Vendor Managed Inventory PAC/JIT Contract Strategy and ensure
the contract is renewed or extended in a timely manner.
Maintain and ensure systems and procedures in Procurement Department are in compliance with SOX,
ISO13485, MDSAP, FDA 21CFR Part 820, IVDR, ISO9001, ISO14001, ISO45001 and other regulatory
requirements.
Participate in material review session for non-conforming materials and activate timely return of non-
conforming materials to vendor.
Conduct inventory audit at Supplier sites where appropriate and report discrepancy and follow up actions
with the suppliers.
Manage and control of raw material inventory level to optimize stock turnover to achieve desired company
inventory turn objective.
Date Posted: 25/09/2025
Job ID: 127157149
Thermo Fisher Scientific Inc. is an American supplier of scientific instrumentation, reagents and consumables, and software services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including: Life Technologies Corporation (2013), Alfa Aesar (2015),Affymetrix (2016),FEI Company (2016), BD Advanced Bioprocessing (2018),and PPD (2021).
As of 2017, the company had a market capitalization of $21 billion and was a Fortune 500 company. Annual revenue in 2021 was US$39.21 billion.
In March 2020, Thermo Fisher Scientific received emergency use authorization from the FDA for a test for SARS-CoV-2 to help mitigate the COVID-19 pandemic.